These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. Monoamine oxidase A inhibition as monotherapy reverses parkinsonism in the MPTP-lesioned marmoset. Hamadjida A; Nuara SG; Frouni I; Kwan C; Bédard D; Gourdon JC; Huot P Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2139-2144. PubMed ID: 32601846 [TBL] [Abstract][Full Text] [Related]
19. Nefazodone reduces dyskinesia, but not psychosis-like behaviours, in the parkinsonian marmoset. Hamadjida A; Nuara SG; Bédard D; Frouni I; Kwan C; Gourdon JC; Huot P Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1339-1345. PubMed ID: 30088028 [TBL] [Abstract][Full Text] [Related]
20. L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model. Ando K; Inoue T; Itoh T Pharmacol Biochem Behav; 2014 Dec; 127():62-9. PubMed ID: 25449794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]